Amid the coronavirus pandemic, India faced a major challenge in securing enough vaccines for its population. The government sought to have foreign companies producing vaccines in India, but faced opposition from the likes of Pfizer and Moderna. These companies had terms that the Government of India eventually rejected.
In today’s DNA, Zee News’ Rohit Ranjan will discuss how Pfizer and Moderna’s attempts to force the Indian government to accept their terms have not been successful. And how India emerged as a provider of Covid vaccine globally.
#DNA : Loot in the name of Corona, loot by making vaccine!#Pfizer #coronavaccine @irohitr pic.twitter.com/owH5QTcrBW– Zee News (@ZeeNews) January 20, 2023
Opponents of the government have criticized its handling of the vaccine situation, but a recent video of Pfizer CEO Albert Bourla struggling to answer questions about the effectiveness of Pfizer’s vaccine calls into question the company’s own credibility. Have given. Pfizer had claimed that its vaccine is 100 percent effective in preventing corona virus infection, but this claim has raised questions.
The race to develop a coronavirus vaccine has seen competition from companies such as Pfizer and Moderna, as well as Russia’s Sputnik vaccine to be the first and most effective. However, attempts by Pfizer and Moderna to enter the Indian market met with resistance, as the Indian government did not accept the conditions put forth by the companies.
India eventually made the difficult decision not to bow to the demands of these foreign companies, and instead rely on domestically produced vaccines such as Covishield and Covaxin. The country’s population has been hit hard by the pandemic, with a second wave in November 2021 recording more than 100,000 cases per day.
In the end, Pfizer and Moderna’s attempts to enter the Indian market were unsuccessful, and India decided to prioritize its citizens and domestic vaccine production rather than succumb to the demands of foreign companies. The video of Pfizer CEO Albert Bourla struggling to answer questions about the effectiveness of Pfizer’s vaccine only serves to highlight the importance of this decision.